PD-L1+MDSCs are increased in HCC patients and induced by soluble factor in the tumor microenvironment
Citations Over TimeTop 10% of 2016 papers
Abstract
Myeloid-derived suppressor cells (MDSCs) could have important roles in immune regulation, and MDSCs can be induced in patients with various malignant tumors. The immune-suppressive functions of MDSCs in hepatocellular carcinoma (HCC) patients have not been clarified. Therefore, we tried to analyze the biological significance of MDSCs in HCC patients. We quantified PD-L1+MDSCs of HCC patients in various conditions by using multi-color flow cytometry analysis. PBMCs from HCC patients contained significantly higher percentages of PD-L1+MDSCs in comparison to those from healthy subjects (p +MDSCs were reduced by curative treatment for HCC (p +MDSCs before treatment were inversely correlated with disease-free survival time. After we cocultivated PBMCs and several liver cancer cell lines in a transwell coculture system, the percentages of PD-L1+MDSCs were significantly increased compared with control (p +MDSCs. Peripheral blood from HCC patients had significantly higher percentages of PD-L1+MDSCs in comparison to those of healthy subjects, and the percentages of PD-L1+MDSCs were reduced by HCC treatment, suggesting that we might use PD-L1+MDSCs as a new biomarker of HCC.
Related Papers
- → Immunometabolism in the tumor microenvironment and its related research progress(2022)28 cited
- → High efficiency temperature-sensitive amber suppressor strains of Escherichia coli K12(1980)23 cited
- → High efficiency temperature-sensitive amber suppressor strains of Escherichia coli K12: Isolation of strains with suppressor-enhancing mutations(1980)20 cited
- → CON A INDUCED SUPPRESSOR TEST AN EVALUATION OF THE EXPERIMENTAL CONDITIONS(1982)5 cited
- Suppressor cells and malignancy. I. Suppressor macrophages and suppressor T cells in experimental animals.(1986)